
Global Targeted DNA Sequencing Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Targeted DNA Sequencing market size will reach US$ million by 2031.
Targeted DNA sequencing is a technique for separating genomes or genomic regions. The technology enables researchers to analyze data, focus time and expense on the target target area, and allows sequencing at advanced exposure levels. Targeted DNA sequencing is an important tool for analyzing mutations in specified samples.
Targeted DNA sequencing plays an important role in sequencing. It has scalability and rapid assessment of target targeted genes. By reducing costs and saving time, multiple genes can be evaluated at once, and a smaller and manageable data set can be generated.
LPI (LP Information)' newest research report, the “Targeted DNA Sequencing Industry Forecast” looks at past sales and reviews total world Targeted DNA Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted DNA Sequencing sales for 2025 through 2031. With Targeted DNA Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted DNA Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Targeted DNA Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted DNA Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted DNA Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted DNA Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted DNA Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted DNA Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Others
Segmentation by Application:
Academic Research
Hospitals and Clinics
Pharma
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina, Inc.
Roche
Agilent Technologies
PierianDx
Genomatix GmbH
GATC Biotech
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
QIAGEN
BGI
PerkinElmer, Inc.
Please note: The report will take approximately 2 business days to prepare and deliver.
Targeted DNA sequencing is a technique for separating genomes or genomic regions. The technology enables researchers to analyze data, focus time and expense on the target target area, and allows sequencing at advanced exposure levels. Targeted DNA sequencing is an important tool for analyzing mutations in specified samples.
Targeted DNA sequencing plays an important role in sequencing. It has scalability and rapid assessment of target targeted genes. By reducing costs and saving time, multiple genes can be evaluated at once, and a smaller and manageable data set can be generated.
LPI (LP Information)' newest research report, the “Targeted DNA Sequencing Industry Forecast” looks at past sales and reviews total world Targeted DNA Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted DNA Sequencing sales for 2025 through 2031. With Targeted DNA Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted DNA Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Targeted DNA Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted DNA Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted DNA Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted DNA Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted DNA Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted DNA Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Others
Segmentation by Application:
Academic Research
Hospitals and Clinics
Pharma
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina, Inc.
Roche
Agilent Technologies
PierianDx
Genomatix GmbH
GATC Biotech
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
QIAGEN
BGI
PerkinElmer, Inc.
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
109 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.